Sign inJoin waitlistJoin the waitlist

YT

Ying Taur

Associate Attending Physician, Infectious Diseases · New York Presbyterian Hospital

Credentials: · · · ·

History

New York Presbyterian Hospital
Present

Infectious Disease
Memorial Sloan Kettering Cancer Center
2006–2008
Internal Medicine
Long Island Jewish Medical Center - Northwell Health
2003–2006
New York Medical College
1999–2003

Research

Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Nature · 2015 · 1,470 citations
Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation
Clinical Infectious Diseases · 2012 · First of 14 authors · Corresponding · 811 citations
Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans
Journal of Clinical Investigation · 2010 · 740 citations

Eric Pamer
45 papers
Marcel van den Brink
41 papers
JP
Jonathan Peled
33 papers · 2 as a fellow
MP
Miguel-Angel Perales
25 papers
Robert Jenq
19 papers
SM
Sejal Morjaria
18 papers · 4 as a fellow
SG
Sergio Giralt
18 papers
TH
Tobias Hohl
12 papers
Emily Marcinkowski
11 papers · 1 as a fellow
Kate Markey
11 papers
AC
Annelie Clurman
10 papers
Anthony Sung
9 papers

Grants

Mathematical Ecology Models of Host-Microbiota Interaction in Auto Microbiota Transplants (Auto-FMT)
National Institute of Allergy and Infectious Diseases · R01
PI · $3.8M · Sloan-Kettering Inst Can Research
2019–2024
Mathematical Ecology Models of Host-Microbiota Interaction in Auto Microbiota Transplants (Auto-FMT)
National Institute of Allergy and Infectious Diseases · R56
PI · $429.3K · Sloan-Kettering Inst Can Research
2018–2019
Effects of the Intestinal Microbiota on Infections During Bone Marrow Transplant
National Institute of Allergy and Infectious Diseases · K23
Contact PI · $650.6K · Sloan-Kettering Inst Can Research
2011–2017

Clinical trials

Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2014–2026